There were 506 press releases posted in the last 24 hours and 212,014 in the last 365 days.

Drug Screening Market Size to Reach USD 13.56 Billion by 2027 | Increased incidence of drug abuse will Propel the Industry Growth, says Emergen Research

The global drug screening market was valued at USD 3.83 Billion in 2019 and is projected to reach USD 13.56 Billion by 2027, at a CAGR of 17.1% during the forecast period.

/EIN News/ -- Vancouver, British Columbia, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The global drug screening market is expected to reach a market size of USD 13.56 Billion by 2027 growing at a CAGR of 17.1% over the forecast period, according to a current analysis by Emergen Research. Drug screening has become mandatory at workplaces to ensure a sober and addiction-free workforce. Healthy workforce helps in increasing productivity and enhancing the work environment. Moreover, the growing trend of doping to perform better in professional sports has also augmented demand for drug screening.

The drug screening process has become quite common at airports and railway stations to ensure the safety of the local population. Intake of excess of alcohol by elderly as well as young individuals, and rise in drug abuse of prescribed medicine are other factors expected to boost market growth in the near future.

In certain countries, drug testing is a violation of rights, and alcohol consumption is banned in some countries. These are two factors that can be unique is either situation and act as a driving factor in one situation, and a restraint in the other. The rising usage of advanced technologies in developing economies is further opening up lucrative growth opportunities for players in the market. Development and adoption of new methods for drug screening are expected to fuel market growth in the next few years.

Claim Your FREE Sample Copy with Table of content@

Companies Profiled in this Report are:

Quest Diagnostics, LabCorp, Drägerwerk, Thermo Fisher Scientific, Alfa Scientific Designs, Omega Laboratories, Roche Diagnostics Limited, Siemens Healthineers, Premier Biotech, and Psychemedics

Key Highlights of Report

  • In August 2020, with the support of Five Arrows Capital Partners, Averhealth acquired drug testing services of Treatment Assessment Screening Center (TASC), which is a private nonprofit organization based in Phoenix, Arizona (the U.S.).
  • The rapid testing devices segment held the largest market share in 2019, owing to several advantages related to use and adoption of these devices. Tests can be performed on patients in resource-limited settings using these devices and results are obtained rapidly. The tests are also more cost-effective as well as highly reliable.  
  • The urine testing devices segment dominated other product and service segments in the drug screening market in 2019. Urine tests are painless and can be used to easily detect presence of any illegal drugs or prescription medicines. These devices can also help doctors to understand potential drug abuse issues.
  • Health workers are at a higher risk of drug abuse. Hospital employees have to undergo drug screening tests to maintain a healthy working environment. Hospitals also test the admitted patients with severe drug abuse issues.
  • The Asia Pacific market revenue is expected to expand at the highest CAGR as compared to that of other regions during the forecast period, primarily due to high demand from India and China. Development of advanced drugs and increase in the number of drug addicts are likely to boost growth of the market in the region during the forecast period.

Check Our Prices@
For the purpose of this report, Emergen Research has segmented the global drug screening market based on product and service, sample type, end-use, and region as follows:

  • Product and Service Outlook (Revenue, USD Billion; 2017–2027)
    • Drug Screening Products
      1. Analytical Instruments
        • Immunoassay Analyzers
        • Chromatography Instruments
        • Breathalyzers
          • Fuel-cell Breathalyzers
          • Semiconductor  Breathalyzers
          • Other Breathalyzers
      2. Rapid Testing Devices
        • Urine Testing Devices
          • Drug Testing Cups
          • Dip Cards
          • Drug Testing Cassettes
        • Oral Fluid Testing Devices
      3. Consumables
      4. Assay Kits
      5. Sample Collection Tubes
      6. Calibrators & Controls
      7. Other Consumables
    • Drug Screening Services
  • Sample Type Outlook (Revenue, USD Billion; 2017–2027)
    • Urine Samples
    • Hair Samples
    • Breath Samples
    • Oral Fluid Samples
    • Other Samples
  • End-use Outlook (Revenue, USD Billion; 2017–2027)
    • Workplaces
    • Criminal Justice Systems & Law Enforcement Agencies
    • Drug Testing Laboratories
    • Drug Treatment Centers
    • Hospitals
    • Pain Management Centers
    • Individual Users
    • Schools & Colleges

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

  • Regional Outlook (Revenue, USD Billion; 2017–2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@

Primary Logo